Suzuki K - Search Results

1

The effects of ICRF-154 in combination with other anticancer agents in vitro.

Kano Y, Narita T, Suzuki K, Akutsu M, Suda K, Sakamoto S, Miura Y. Kano Y, et al. Among authors: suzuki k. Br J Cancer. 1992 Aug;66(2):281-6. doi: 10.1038/bjc.1992.257. Br J Cancer. 1992. PMID: 1503899 Free PMC article.

2

Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines.

Kano Y, Akutsu M, Suzuki K, Yoshida M. Kano Y, et al. Among authors: suzuki k. Leuk Res. 1993 Feb;17(2):113-9. doi: 10.1016/0145-2126(93)90055-p. Leuk Res. 1993. PMID: 8429687

3

In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines.

Kano Y, Akutsu M, Tsunoda S, Mori K, Suzuki K, Adachi KI. Kano Y, et al. Among authors: suzuki k. Cancer Chemother Pharmacol. 1998;42(2):91-8. doi: 10.1007/s002800050790. Cancer Chemother Pharmacol. 1998. PMID: 9654107

4

Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines.

Yazawa Y, Takagi T, Asakura S, Suzuki K, Kano Y. Yazawa Y, et al. Among authors: suzuki k. J Orthop Sci. 1999;4(3):231-7. doi: 10.1007/s007760050098. J Orthop Sci. 1999. PMID: 10370165

5

Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro.

Kano Y, Akutsu M, Suzuki K, Mori K, Yazawa Y, Tsunoda S. Kano Y, et al. Among authors: suzuki k. Cancer Chemother Pharmacol. 1999;44(5):381-8. doi: 10.1007/s002800050993. Cancer Chemother Pharmacol. 1999. PMID: 10501911

6

Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro.

Kano Y, Akutsu M, Suzuki K, Ando J, Tsunoda S. Kano Y, et al. Among authors: suzuki k. Breast Cancer Res Treat. 1999 Jul;56(1):79-90. doi: 10.1023/a:1006254315174. Breast Cancer Res Treat. 1999. PMID: 10517345

7

In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.

Kano Y, Akutsu M, Tsunoda S, Suzuki K, Ichikawa A, Furukawa Y, Bai L, Kon K. Kano Y, et al. Among authors: suzuki k. Leukemia. 2000 Mar;14(3):379-88. doi: 10.1038/sj.leu.2401684. Leukemia. 2000. PMID: 10720130

8

Schedule-dependent synergism and antagonism between raltitrexed ("Tomudex") and methotrexate in human colon cancer cell lines in vitro.

Kano Y, Akutsu M, Tsunoda S, Suzuki K, Yazawa Y, Furukawa Y. Kano Y, et al. Among authors: suzuki k. Jpn J Cancer Res. 2001 Jan;92(1):74-82. doi: 10.1111/j.1349-7006.2001.tb01050.x. Jpn J Cancer Res. 2001. PMID: 11173547 Free PMC article.

9

Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro.

Kano Y, Akutsu M, Tsunoda S, Ando J, Matsui J, Suzuki K, Ikeda T, Inoue Y, Adachi K. Kano Y, et al. Among authors: suzuki k. Br J Cancer. 1996 Sep;74(5):704-10. doi: 10.1038/bjc.1996.425. Br J Cancer. 1996. PMID: 8795571 Free PMC article.

10

Effects of 13-hydroxy SM5887 in combination with other anticancer agents on human tumor cell lines.

Takagi T, Yazawa Y, Suzuki K, Yamauchi Y, Kano Y. Takagi T, et al. Among authors: suzuki k. Invest New Drugs. 1996;14(4):357-63. doi: 10.1007/BF00180811. Invest New Drugs. 1996. PMID: 9157070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,762 results

Search Page

Filters